Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class I · High risk

Slim-K

Marketed Without An Approved NDA/ANDA: Product was found to contain sibutramine, desmethylsibutramine and phenolphthalein based on FDA sampling and analysis.

Terminated Chemical / undeclared Bethel Nutritional Consulting, Inc D-1207-2015
Class II · Moderate risk

B-Lipo

Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss

Terminated Unapproved drug Bethel Nutritional Consulting, Inc D-0424-2015
Class III · Low risk

3M ESPE Clinpro 5000

Labeling: Incorrect or Missing Lot and/or Exp. Date - The subject lot is missing the lot number and expiration date stamp on the primary box..

Terminated Labeling / mix-up 3M Company/3m Espe Dental Products NDC 48878-3130-04 D-0376-2015
Class I · High risk

Virginia Hospital Center

Non-Sterility: Out of specification results for the sterility test for microbial contamination.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-470-2015
Class I · High risk

Bayshore Medical Center

Non-Sterility: Out of specification results for the sterility test for microbial contamination.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-466-2015
Class I · High risk

Bayshore Medical Center

Non-Sterility: Out of specification results for the sterility test for microbial contamination.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-465-2015
Class I · High risk

Lankenau Hospital

Non-Sterility: Out of specification results for the sterility test for microbial contamination.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-464-2015

Recalls by year